Cliff Asness's RGNX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.05 M shares of REGENXBIO Inc. (RGNX) worth $8.81 M, representing 0.00% of the portfolio. First purchased in 2017-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in RGNX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 594,161 shares. Largest reduction occurred in Q1 2026, reducing 310,250 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's REGENXBIO (RGNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly REGENXBIO (RGNX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -310,250 | Reduce 22.78% | 1.05 M | $8.38 |
| Q4 2025 | +72,307 | Add 5.61% | 1.36 M | $14.40 |
| Q3 2025 | +359,459 | Add 38.64% | 1.29 M | $9.65 |
| Q2 2025 | +309,601 | Add 49.89% | 930,196 | $8.21 |
| Q1 2025 | +594,161 | Add 2247.72% | 620,595 | $7.15 |
| Q4 2024 | -9,823 | Reduce 27.09% | 26,434 | $7.73 |
| Q3 2024 | +15,878 | Add 77.91% | 36,257 | $10.49 |
| Q2 2024 | +20,379 | New Buy | 20,379 | $11.70 |
| Q1 2024 | -22,052 | Sold Out | 0 | $0.00 |
| Q4 2023 | -27 | Reduce 0.12% | 22,052 | $17.95 |
| Q3 2023 | -2,477 | Reduce 10.09% | 22,079 | $16.46 |
| Q2 2023 | -58,746 | Reduce 70.52% | 24,556 | $19.99 |
| Q1 2023 | -155,613 | Reduce 65.13% | 83,302 | $18.91 |
| Q4 2022 | +45,411 | Add 23.47% | 238,915 | $22.68 |
| Q3 2022 | +50,439 | Add 35.26% | 193,504 | $26.43 |
| Q2 2022 | +102,574 | Add 253.33% | 143,065 | $24.70 |
| Q1 2022 | +40,491 | New Buy | 40,491 | $33.19 |
| Q2 2021 | -8,786 | Sold Out | 0 | $0.00 |
| Q1 2021 | +3,278 | Add 59.51% | 8,786 | $34.15 |
| Q4 2020 | -9,286 | Reduce 62.77% | 5,508 | $45.39 |
| Q3 2020 | +5,313 | Add 56.04% | 14,794 | $27.51 |
| Q2 2020 | +559 | Add 6.27% | 9,481 | $36.81 |
| Q1 2020 | -8,147 | Reduce 47.73% | 8,922 | $32.39 |
| Q4 2019 | -22,885 | Reduce 57.28% | 17,069 | $40.95 |
| Q3 2019 | -100,771 | Reduce 71.61% | 39,954 | $35.59 |
| Q2 2019 | -100,992 | Reduce 41.78% | 140,725 | $51.37 |
| Q1 2019 | -48,933 | Reduce 16.84% | 241,717 | $57.31 |
| Q4 2018 | +78,820 | Add 37.21% | 290,650 | $41.95 |
| Q3 2018 | +35,915 | Add 20.42% | 211,830 | $75.50 |
| Q2 2018 | +115,912 | Add 193.18% | 175,915 | $71.75 |
| Q1 2018 | +26,973 | Add 81.66% | 60,003 | $29.85 |
| Q4 2017 | -4,853 | Reduce 12.81% | 33,030 | $33.24 |
| Q3 2017 | -14,375 | Reduce 27.51% | 37,883 | $32.94 |
| Q2 2017 | +52,258 | New Buy | 52,258 | $19.75 |
Cliff Asness's REGENXBIO Investment FAQs
Cliff Asness first purchased REGENXBIO Inc. (RGNX) in Q2 2017, acquiring 52,258 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held REGENXBIO Inc. (RGNX) for 34 quarters since Q2 2017.
Cliff Asness's largest addition to REGENXBIO Inc. (RGNX) was in Q1 2025, adding 620,595 shares worth $4.44 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,051,712 shares of REGENXBIO Inc. (RGNX), valued at approximately $8.81 M.
As of the Q1 2026 filing, REGENXBIO Inc. (RGNX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in REGENXBIO Inc. (RGNX) was 1,361,962 shares, as reported at the end of Q4 2025.